I'm not sure that there is formal approval required. There is usually an end of Phase 2 meeting with the FDA I think just to get some feedback on what would constitute a successful Phase 3 study design and result. But, I don't think the FDA formally has to approve a Phase 3 start. Someone correct me if I'm wrong on that.